NCT03333616 2026-01-21Nivolumab Combined With Ipilimumab for Patients With Advanced Rare Genitourinary TumorsDana-Farber Cancer InstitutePhase 2 Active not recruiting100 enrolled
NCT07161882 2025-09-16SAFRO2202Société Algérienne de Formation et de Recherche en OncologieRecruiting3,750 enrolled